登录 | 注册    关注公众号  
微信公众号
搜索
 > 【BAFFR】

BAFFR信息

英文名称:B-cell activating factor receptor
中文名称:B细胞活化因子受体
靶点别称:BAFFR,B Cell-Activating Factor Receptor,Prolixin,BROMIX,CD268,Tumor Necrosis Factor Receptor Superfamily, Member 13C,Tumor Necrosis Factor Receptor Superfamily Member 13C,BR3,CVID4,CD268 Antigen,BAFF Receptor,B-Cell Activation Factor Receptor,BAFF-R,TNF Receptor Superfamily Member 13C,BLyS Receptor 3,B-Cell-Activating Factor Receptor,TNFRSF13C
上市药物数量:0
临床药物数量:5
最高研发阶段:临床三期

抗体项目交易平台

项目名称 项目阶段 分子类型 分子来源 疾病领域 适应症
BAFFR&CD3 BsAb - 01 PCC 双抗 鼠源人源化,纳米抗体 血液瘤,自免 系统性红斑狼疮,B细胞淋巴瘤

Licensing 项目合作

项目名称 药物类型 治疗领域 适应症 阶段 权益地区
BAFFR×CD3双特异性抗体 双抗,多抗 肿瘤学,癌症 B细胞恶性肿瘤、自身免疫性疾病 临床前 全球

BAFFR分子别名

BAFFR,TNFRSF13C,BROMIX,CD268,CVID4,prolixin,BAFF-R

BAFFR分子背景

BAFF receptor (B-cell activating factor receptor, BAFF-R), also known as tumor necrosis factor receptor superfamily member 13C (TNFRSF13C), is a membrane protein of the TNF receptor superfamily which recognizes BAFF. B-cell activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of BAFF in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells.

BAFFR临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定